GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
H

Henan Lingrui Pharmaceutical Co 600285.SS · CNY

Health Care · Shanghai · 🇨🇳 China

Compare

23.27

-2.51%

Close of 9 Nov 2026, in CNY

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Analyst ratings

6 analysts, 1 Mar 2026. The analysts' own views, not ours.

  • 2Strong buy
  • 3Buy
  • 1Hold
  • 0Sell
  • 0Strong sell

Price targets

Brokers' own targets, 21 Feb 2026. Not our view.

Average target 29.12

Low
27.37
Average
29.12
Median
29.12
High
31.50

Forecasts

Analyst averages for the fiscal years ahead

FY2026FY2027FY2028
RevenueCN¥4.09bnCN¥4.40bnCN¥4.73bn
Revenue, highestCN¥4.09bnCN¥4.44bnCN¥4.82bn
Revenue, lowestCN¥4.08bnCN¥4.36bnCN¥4.64bn
Earnings per share1.501.621.74
Earnings per share, highest1.511.641.81
Earnings per share, lowest1.481.611.67
Analysts222

Quality and value scores

Models run by our data supplier, not our view and not investment advice

Model

Quality score

10 / 10

Revenue growth 13.5% a year over 10 years. Return on equity 22.3%.

Model fair value

23.85

From earnings 23.85, from revenue 23.52.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.